Thermo Fisher Scientific Inc. (TMO) reported revenue of $44.56B and net profit of $6.70B. Revenue grew 7.2% YoY with a net profit margin of 15.0%. The company maintains strong positioning in the Healthcare sector. BUY | PT USD 559.78 (+18.0% upside).
Access the complete analysis, financial model, price target breakdown, and risk factors.
Read Full Report →2 free reads per day · No credit card required